Literature DB >> 8760730

Growth hormone deficiency and replacement in adults.

S M Shalet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8760730      PMCID： PMC2351760          DOI： 10.1136/bmj.313.7053.314

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy.

Authors:  S P McKenna; L C Doward
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

Review 2.  Clinical aspects of growth hormone deficiency in adults.

Authors:  H de Boer; G J Blok; E A Van der Veen
Journal:  Endocr Rev       Date:  1995-02       Impact factor: 19.871

3.  Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency.

Authors:  D J O'Halloran; A Tsatsoulis; R W Whitehouse; S J Holmes; J E Adams; S M Shalet
Journal:  J Clin Endocrinol Metab       Date:  1993-05       Impact factor: 5.958

4.  Factors influencing the desire for long-term growth hormone replacement in adults.

Authors:  S J Holmes; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1995-08       Impact factor: 3.478

5.  Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.

Authors:  S Edén; O Wiklund; J Oscarsson; T Rosén; B A Bengtsson
Journal:  Arterioscler Thromb       Date:  1993-02

6.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

7.  Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.

Authors:  T B Hansen; N Vahl; J O Jørgensen; J S Christiansen; C Hagen
Journal:  Clin Endocrinol (Oxf)       Date:  1995-12       Impact factor: 3.478

8.  Characteristics of adults who wish to enter a trial of growth hormone replacement.

Authors:  S J Holmes; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1995-06       Impact factor: 3.478

9.  Beta-cell function in hypopituitary adults before and during growth hormone treatment.

Authors:  S A Beshyah; S V Gelding; C Andres; D G Johnston; I P Gray
Journal:  Clin Sci (Lond)       Date:  1995-09       Impact factor: 6.124
  9 in total
  2 in total

1.  Management of pituitary tumours.

Authors:  J S Bevan
Journal:  BMJ       Date:  1999-05-08

Review 2.  Growth hormone therapy and quality of life in adults and children.

Authors:  Deborah J Radcliffe; Joseph S Pliskin; J B Silvers; Leona Cuttler
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.